David Beats Goliath in War Over Words: Court Rules Free Speech Extends to Drug Company’s Marketing Efforts
Far be it from an Alabama law firm to pay undue attention to a federal district court decision in New York. When that distant court issues a lengthy opinion on a trending topic in drug and device litigation, however, we take notice. That is just what happened last Friday in the hotly-watched case of Amarin … Read More

